144 related articles for article (PubMed ID: 6553512)
1. Restoration by levamisole of immune responses suppressed in tumor-bearing mice.
Shiraishi M; Himeno K; Nomoto K
Cancer Immunol Immunother; 1983; 15(2):121-5. PubMed ID: 6553512
[TBL] [Abstract][Full Text] [Related]
2. Restoration of immune response by levamisole in B-77 virus induced tumor-bearing rats.
Kalafut F; Kusenda J; Novotná L; Klobusická M
Neoplasma; 1988; 35(4):369-78. PubMed ID: 2847064
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
Gomi K; Morimoto M; Nomoto K
Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
[TBL] [Abstract][Full Text] [Related]
4. Influence of surgical removal and effect of levamisole on cytotoxic T-cell-mediated antitumor immunity in mice.
Gomi K; Morimoto M; Nomoto K
Cancer Res; 1983 Nov; 43(11):5120-5. PubMed ID: 6604572
[TBL] [Abstract][Full Text] [Related]
5. Chemo-immunotherapy of methylchoranthrene-induced fibrosarcoma by concanavalin A-bound tumor vaccine, levamisole and mitomycin C.
Okabe M; Morimoto M; Marumo H
J Pharmacobiodyn; 1982 Apr; 5(4):245-51. PubMed ID: 6811721
[TBL] [Abstract][Full Text] [Related]
6. [Effects of levamisole on methylcholanthrene-induced tumor. I. Its antitumor effect and immunological mechanism].
Gomi K; Morimoto M; Nomoto K
Gan To Kagaku Ryoho; 1982 Jul; 9(7):1262-8. PubMed ID: 7184454
[TBL] [Abstract][Full Text] [Related]
7. Host-mediated antitumor activity of Lactobacillus casei in mice.
Yasutake N; Kato I; Ohwaki M; Yokokura T; Mutai M
Gan; 1984 Jan; 75(1):72-80. PubMed ID: 6427051
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
Tomazic VJ; Farha M; Loftus A; Elias EG
J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
[TBL] [Abstract][Full Text] [Related]
9. The antitumor effects of levamisole in mice are mediated by NC-1.1+ cells.
Clarke GR; Burton RC; Smart YC
Cancer Immunol Immunother; 1997 Oct; 45(2):115-8. PubMed ID: 9390203
[TBL] [Abstract][Full Text] [Related]
10. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
[TBL] [Abstract][Full Text] [Related]
11. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.
Simmons RL; Rios A; Lundgren G; Ray PK; McKhann CF; Haywood GR
Surgery; 1971 Jul; 70(1):38-46. PubMed ID: 5092115
[No Abstract] [Full Text] [Related]
12. [Depression of protective mechanisms against ectromelia virus infection in tumor-bearing mice and its prevention by PSK].
Taniguchi M; Tsuru S; Kitani H; Zinnaka Y; Nomoto K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2760-5. PubMed ID: 6095765
[TBL] [Abstract][Full Text] [Related]
13. Effect of cyclophosphamide on mice bearing methylcholanthrene-induced fibrosarcomas.
Yu S; Lannin DR; Tsui-Collins AL; McKhann CF
Cancer Res; 1980 Aug; 40(8 Pt 1):2756-61. PubMed ID: 7388826
[TBL] [Abstract][Full Text] [Related]
14. Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors.
Fuyama S; Komatsu H; Arai S
Cell Immunol; 1991 Oct; 137(1):200-15. PubMed ID: 1679379
[TBL] [Abstract][Full Text] [Related]
15. Absence of generalized immunosuppression in C57BL/6J mice implanted with Lewis T241 fibrosarcoma or Lewis lung carcinoma.
Jones CE; Lee CT; Skinner W; Koyama P; Prescott D
Cancer Immunol Immunother; 1984; 18(2):82-6. PubMed ID: 6239684
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy with anti-CD3 monoclonal antibodies and recombinant interleukin 2: stimulation of molecular programs of cytotoxic killer cells and induction of tumor regression.
Nakajima F; Khanna A; Xu G; Lagman M; Haschemeyer R; Mouradian J; Wang JC; Stenzel KH; Rubin AL; Suthanthiran M
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7889-93. PubMed ID: 8058730
[TBL] [Abstract][Full Text] [Related]
17. Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2.
Eberlein TJ; Rosenstein M; Rosenberg SA
J Exp Med; 1982 Aug; 156(2):385-97. PubMed ID: 6980254
[TBL] [Abstract][Full Text] [Related]
18. Dissociation between tumour resistance and delayed-type hypersensitivity to tumour-associated antigens in the mouse.
Henderson DC; Parker D; Turk JL
Immunology; 1980 Jan; 39(1):1-9. PubMed ID: 7380461
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor cytostatic mechanism and delayed-type hypersensitivity against a syngeneic murine tumor. Comparison between neonatally thymectomized mice and congenitally athymic nude mice.
Mitani M; Mori K; Himeno K; Nomoto K
J Immunol; 1989 Mar; 142(6):2148-54. PubMed ID: 2493508
[TBL] [Abstract][Full Text] [Related]
20. Increased resistance in splenectomized mice to a methylcholanthrene-induced tumour.
Chang RW; Turk JL
Br J Cancer; 1977 Jun; 35(6):768-76. PubMed ID: 871366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
